Pharmerica Corporation Stock Price, News & Analysis (NYSE:PMC)

$29.15 0.05 (0.17 %)
(As of 11/17/2017 02:49 PM ET)
Previous Close$29.10
Today's Range$29.10 - $29.15
52-Week Range$22.00 - $29.50
Volume179,000 shs
Average Volume281,076 shs
Market Capitalization$905.6 million
P/E Ratio15.08
Dividend YieldN/A
Beta0.82

About Pharmerica Corporation (NYSE:PMC)

Pharmerica Corporation logoPharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.


Industry, Sector and Symbol:
  • Industry: Drug Retailers
  • Sub-Industry: Health Care Distributors
  • Sector: Medical
  • Symbol: NYSE:PMC
  • CUSIP: 71714F10
  • Web: www.pharmerica.com
Debt:
  • Debt-to-Equity Ratio: 0.79%
  • Current Ratio: 2.58%
  • Quick Ratio: 1.79%
Price-To-Earnings:
  • Trailing P/E Ratio: 15.08
  • Forward P/E Ratio: 15.18
  • P/E Growth: 1.27
Sales & Book Value:
  • Annual Sales: $2.0911 billion
  • Price / Sales: 0.43
  • Cash Flow: $3.86 per share
  • Price / Cash: 7.55
  • Book Value: $18.05 per share
  • Price / Book: 1.61
Profitability:
  • Trailing EPS: $0.61
  • Net Income: $21.6 million
  • Net Margins: 0.83%
  • Return on Equity: 10.94%
  • Return on Assets: 4.79%
Misc:
  • Employees: 5,700
  • Outstanding Shares: 31,120,000
 
Frequently Asked Questions for Pharmerica Corporation (NYSE:PMC)

What is Pharmerica Corporation's stock symbol?

Pharmerica Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "PMC."

How were Pharmerica Corporation's earnings last quarter?

Pharmerica Corporation (NYSE:PMC) issued its quarterly earnings results on Thursday, November, 9th. The company reported $0.46 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.49 by $0.03. The firm had revenue of $595.10 million for the quarter, compared to the consensus estimate of $596.80 million. Pharmerica Corporation had a return on equity of 10.94% and a net margin of 0.83%. View Pharmerica Corporation's Earnings History.

When will Pharmerica Corporation make its next earnings announcement?

Pharmerica Corporation is scheduled to release their next quarterly earnings announcement on Friday, February, 23rd 2018. View Earnings Estimates for Pharmerica Corporation.

Where is Pharmerica Corporation's stock going? Where will Pharmerica Corporation's stock price be in 2017?

3 Wall Street analysts have issued 12-month price targets for Pharmerica Corporation's stock. Their forecasts range from $29.25 to $29.25. On average, they anticipate Pharmerica Corporation's stock price to reach $29.25 in the next year. View Analyst Ratings for Pharmerica Corporation.

Who are some of Pharmerica Corporation's key competitors?

Who are Pharmerica Corporation's key executives?

Pharmerica Corporation's management team includes the folowing people:

  • Geoffrey G. Meyers, Independent Chairman of the Board (Age 72)
  • Gregory S. Weishar, Chief Executive Officer, Director (Age 62)
  • Suresh Vishnubhatla, Executive Vice President - Long-term Care Operations (Age 48)
  • Berard E. Tomassetti, Senior Vice President, Chief Accounting Officer (Age 61)
  • Thomas A. Caneris, Senior Vice President, General Counsel, Secretary (Age 54)
  • Robert A. McKay, Senior Vice President - Purchasing and Trade Relations (Age 55)
  • Frank E. Collins Esq., Independent Director (Age 63)
  • W. Robert Robert Dahl Jr., Independent Director (Age 60)
  • Marjorie W. Dorr, Independent Director (Age 55)
  • Patrick G. LePore, Independent Director (Age 62)

Who owns Pharmerica Corporation stock?

Pharmerica Corporation's stock is owned by a number of of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (8.39%), Boston Partners (4.62%), JPMorgan Chase & Co. (1.37%), Allianz Asset Management GmbH (1.28%), Ameriprise Financial Inc. (0.97%) and SG Americas Securities LLC (0.90%). Company insiders that own Pharmerica Corporation stock include Edward Leith Ellwood, Paul Valerian Teodorovici and Robert A Mckay. View Institutional Ownership Trends for Pharmerica Corporation.

Who sold Pharmerica Corporation stock? Who is selling Pharmerica Corporation stock?

Pharmerica Corporation's stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, Wells Fargo & Company MN, Citadel Advisors LLC, Municipal Employees Retirement System of Michigan, Ameriprise Financial Inc., New York State Common Retirement Fund, Segall Bryant & Hamill LLC and Dimensional Fund Advisors LP. Company insiders that have sold Pharmerica Corporation company stock in the last year include Edward Leith Ellwood and Paul Valerian Teodorovici. View Insider Buying and Selling for Pharmerica Corporation.

Who bought Pharmerica Corporation stock? Who is buying Pharmerica Corporation stock?

Pharmerica Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, SG Americas Securities LLC, Commonwealth of Pennsylvania Public School Empls Retrmt SYS, Gabelli Funds LLC, JPMorgan Chase & Co., ARP Americas LLC, Kassirer Asset Management Corp and GABELLI & Co INVESTMENT ADVISERS INC.. View Insider Buying and Selling for Pharmerica Corporation.

How do I buy Pharmerica Corporation stock?

Shares of Pharmerica Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pharmerica Corporation's stock price today?

One share of Pharmerica Corporation stock can currently be purchased for approximately $29.15.

How big of a company is Pharmerica Corporation?

Pharmerica Corporation has a market capitalization of $905.6 million and generates $2.0911 billion in revenue each year. The company earns $21.6 million in net income (profit) each year or $0.61 on an earnings per share basis. Pharmerica Corporation employs 5,700 workers across the globe.

How can I contact Pharmerica Corporation?

Pharmerica Corporation's mailing address is 1901 CAMPUS PLACE, LOUISVILLE KY, 40299. The company can be reached via phone at 502-627-7000.


MarketBeat Community Rating for Pharmerica Corporation (NYSE PMC)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  122 (Vote Outperform)
Underperform Votes:  186 (Vote Underperform)
Total Votes:  308
MarketBeat's community ratings are surveys of what our community members think about Pharmerica Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Ratings for Pharmerica Corporation (NYSE:PMC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $29.25 (0.34% upside)
Consensus Price Target History for Pharmerica Corporation (NYSE:PMC)
Price Target History for Pharmerica Corporation (NYSE:PMC)
Analysts' Ratings History for Pharmerica Corporation (NYSE:PMC)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/9/2017Barrington ResearchDowngradeOutperform -> UnderperformLowView Rating Details
8/8/2017KeyCorpDowngradeOverweightLowView Rating Details
8/4/2017Credit Suisse GroupDowngradeOutperform -> Neutral$29.00 -> $29.25LowView Rating Details
6/7/2016Bank of America CorporationInitiated CoverageBuy$32.00N/AView Rating Details
2/29/2016Barclays PLCLower Price TargetUnderweight$27.00 -> $22.00N/AView Rating Details
12/30/2015Cowen and CompanyReiterated RatingBuy$39.00 -> $41.00N/AView Rating Details
(Data available from 11/17/2015 forward)

Earnings

Earnings History for Pharmerica Corporation (NYSE:PMC)
Earnings by Quarter for Pharmerica Corporation (NYSE:PMC)
Earnings History by Quarter for Pharmerica Corporation (NYSE PMC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/23/2018        
11/9/2017Q3 2017$0.49$0.46$596.80 million$595.10 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.47$0.47$592.96 million$592.00 millionViewN/AView Earnings Details
5/10/2017Q1 2017$0.40$0.42$536.85 million$566.80 millionViewN/AView Earnings Details
2/24/2017Q416$0.51$0.58$525.22 million$534.40 millionViewListenView Earnings Details
11/9/2016Q316$0.51$0.44$530.01 million$512.60 millionViewListenView Earnings Details
8/9/2016Q216$0.47$0.47$508.31 million$519.60 millionViewListenView Earnings Details
5/6/2016Q116$0.43$0.45$509.45 million$524.50 millionViewListenView Earnings Details
2/26/2016Q415$0.41$0.45$506.40 million$520.60 millionViewListenView Earnings Details
11/6/2015Q315$0.36$0.39$480.35 million$498.80 millionViewListenView Earnings Details
8/7/2015Q215$0.33$0.37$491.66 million$497.50 millionViewListenView Earnings Details
5/7/2015Q115$0.43$0.48$500.95 million$511.60 millionViewListenView Earnings Details
3/2/2015Q414$0.43$0.45$491.99 million$523.50 millionViewListenView Earnings Details
11/6/2014Q314$0.40$0.45$439.63 million$470.20 millionViewListenView Earnings Details
8/5/2014Q214$0.36$0.40$432.70 million$448.60 millionViewListenView Earnings Details
5/1/2014Q114$0.33$0.37$417.76 million$452.20 millionViewListenView Earnings Details
2/28/2014Q413$0.38$0.44$421.16 million$433.20 millionViewListenView Earnings Details
11/5/2013Q313$0.32$0.49$398.02 million$442.00 millionViewListenView Earnings Details
8/2/2013Q2 2013$0.34$0.44$414.15 million$458.50 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.34$0.46$435.10 million$439.80 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.29$0.12$432.43 million$433.20 millionViewListenView Earnings Details
11/1/2012Q312$0.30$0.33$446.36 million$442.00 millionViewN/AView Earnings Details
8/2/2012$0.30$0.32ViewN/AView Earnings Details
5/2/2012$0.27$0.30ViewN/AView Earnings Details
2/9/2012$0.21$0.27ViewN/AView Earnings Details
11/3/2011$0.20$0.31ViewN/AView Earnings Details
8/4/2011$0.20$0.32ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/24/2011$0.17$0.16ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pharmerica Corporation (NYSE:PMC)
2017 EPS Consensus Estimate: $1.88
2018 EPS Consensus Estimate: $2.12
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.40$0.40$0.40
Q2 20172$0.46$0.47$0.47
Q3 20172$0.49$0.50$0.50
Q4 20172$0.51$0.53$0.52
Q1 20181$0.46$0.46$0.46
Q2 20181$0.52$0.52$0.52
Q3 20181$0.55$0.55$0.55
Q4 20181$0.59$0.59$0.59
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Pharmerica Corporation (NYSE:PMC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Pharmerica Corporation (NYSE PMC)
Insider Ownership Percentage: 5.04%
Institutional Ownership Percentage: 86.49%
Insider Trades by Quarter for Pharmerica Corporation (NYSE:PMC)
Insider Trades by Quarter for Pharmerica Corporation (NYSE:PMC)
Insider Trades by Quarter for Pharmerica Corporation (NYSE PMC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/2/2017Paul Valerian TeodoroviciDirectorSell8,000$0.09$720.00
10/5/2017Edward Leith EllwoodInsiderSell3,000$0.10$300.00
10/3/2017Edward Leith EllwoodInsiderSell2,000$0.10$200.00
8/17/2017Edward Leith EllwoodInsiderSell20,000$0.09$1,800.00
7/27/2017Edward Leith EllwoodInsiderSell3,000$0.08$240.00
7/25/2017Edward Leith EllwoodInsiderSell1,000$0.08$80.00
3/31/2017Edward Leith EllwoodInsiderSell35,000$0.07$2,450.00
12/2/2015Robert A MckaySVPSell2,993$34.42$103,019.06View SEC Filing  
11/11/2015Mark LindemoenSVPSell3,790$34.71$131,550.90View SEC Filing  
6/16/2015Robert A MckaySVPSell7,000$32.75$229,250.00View SEC Filing  
6/3/2015Gregory S WeisharCEOSell104,150$32.63$3,398,414.50View SEC Filing  
6/1/2015Mark LindemoenSVPSell4,500$33.27$149,715.00View SEC Filing  
3/12/2015Berard TomassettiCAOSell3,344$26.44$88,415.36View SEC Filing  
3/12/2015Thomas A CanerisSVPSell7,495$26.52$198,767.40View SEC Filing  
3/6/2015Robert A MckaySVPSell20,000$26.74$534,800.00View SEC Filing  
8/8/2014Robert A OakleyDirectorSell8,399$26.55$222,993.45View SEC Filing  
5/13/2014Thomas CanerisSVPSell12,192$28.60$348,691.20View SEC Filing  
3/14/2014Gregory WeisharCEOSell60,000$26.27$1,576,200.00View SEC Filing  
3/13/2014Robert MckaySVPSell18,646$26.08$486,287.68View SEC Filing  
3/12/2014Berard TomassettiCAOSell3,812$25.22$96,138.64View SEC Filing  
3/6/2014Thomas CanerisSVPSell14,357$25.60$367,539.20View SEC Filing  
11/22/2013Thomas GerrityDirectorSell3,271$20.56$67,251.76View SEC Filing  
11/15/2013Berard TomassettiCAOSell4,097$20.55$84,193.35View SEC Filing  
5/30/2013Berard TomassettiCAOSell9,724$15.68$152,472.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Pharmerica Corporation (NYSE:PMC)
Latest Headlines for Pharmerica Corporation (NYSE PMC)
Source:
DateHeadline
Zacks: Brokerages Expect Pharmerica Corporation (PMC) Will Post Quarterly Sales of $614.00 MillionZacks: Brokerages Expect Pharmerica Corporation (PMC) Will Post Quarterly Sales of $614.00 Million
www.americanbankingnews.com - November 15 at 11:08 AM
PharMerica shareholders vote on $1.4 billion acquisitionPharMerica shareholders vote on $1.4 billion acquisition
finance.yahoo.com - November 12 at 11:44 AM
PharMerica Reports Third Quarter 2017 ResultsPharMerica Reports Third Quarter 2017 Results
finance.yahoo.com - November 12 at 11:44 AM
PharMerica posts 3Q profitPharMerica posts 3Q profit
finance.yahoo.com - November 12 at 11:44 AM
Why PharMerica Corporation (PMC) Delivered An Inferior ROE Compared To The IndustryWhy PharMerica Corporation (PMC) Delivered An Inferior ROE Compared To The Industry
finance.yahoo.com - November 12 at 11:44 AM
Pharmerica Corporation (PMC) Receives Average Rating of "Hold" from AnalystsPharmerica Corporation (PMC) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - November 11 at 1:46 AM
Pharmerica Corporation (PMC) Announces Quarterly  Earnings ResultsPharmerica Corporation (PMC) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 10 at 3:36 PM
PharMerica misses by $0.06, misses on revenuePharMerica misses by $0.06, misses on revenue
seekingalpha.com - November 9 at 3:38 PM
PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 7, 2017PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 7, 2017
finance.yahoo.com - November 7 at 8:50 AM
PharMerica Corp. – Value Analysis (NYSE:PMC) : October 30, 2017PharMerica Corp. – Value Analysis (NYSE:PMC) : October 30, 2017
finance.yahoo.com - October 31 at 8:00 AM
Pharmerica Corporation (PMC) Scheduled to Post Earnings on TuesdayPharmerica Corporation (PMC) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - October 31 at 2:50 AM
ETFs with exposure to PharMerica Corp. : October 26, 2017ETFs with exposure to PharMerica Corp. : October 26, 2017
finance.yahoo.com - October 27 at 10:46 AM
PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : October 27, 2017PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : October 27, 2017
finance.yahoo.com - October 27 at 10:46 AM
Onco360 Selected for VERZENIO® Limited Distribution Pharmacy NetworkOnco360 Selected for VERZENIO® Limited Distribution Pharmacy Network
finance.yahoo.com - October 17 at 6:20 AM
Pharmerica Corporation (PMC) Receives Consensus Recommendation of "Hold" from AnalystsPharmerica Corporation (PMC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - October 17 at 2:52 AM
PharMerica details millions in golden parachute money for executivesPharMerica details millions in golden parachute money for executives
finance.yahoo.com - October 7 at 7:26 AM
BEHIND THE DEAL: PharMerica reveals how its $1.4 billion acquisition came togetherBEHIND THE DEAL: PharMerica reveals how its $1.4 billion acquisition came together
www.bizjournals.com - October 5 at 9:52 PM
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against PharMerica CorporationFaruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against PharMerica Corporation
finance.yahoo.com - October 5 at 4:49 PM
PharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017PharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
finance.yahoo.com - October 3 at 10:52 AM
Pharmerica Corporation (PMC) Short Interest UpdatePharmerica Corporation (PMC) Short Interest Update
www.americanbankingnews.com - October 3 at 3:32 AM
Pharmerica Corporation (PMC) Expected to Post Quarterly Sales of $596.80 MillionPharmerica Corporation (PMC) Expected to Post Quarterly Sales of $596.80 Million
www.americanbankingnews.com - September 23 at 9:28 AM
Pharmerica Corporation (PMC) Given Average Rating of "Hold" by BrokeragesPharmerica Corporation (PMC) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 22 at 2:34 AM
PharMerica Corporation -- Moodys assigns B2 CFR to PharMerica Corporation; outlook stablePharMerica Corporation -- Moody's assigns B2 CFR to PharMerica Corporation; outlook stable
finance.yahoo.com - September 13 at 7:54 AM
$596.80 Million in Sales Expected for Pharmerica Corporation (PMC) This Quarter$596.80 Million in Sales Expected for Pharmerica Corporation (PMC) This Quarter
www.americanbankingnews.com - September 4 at 4:52 AM
Pharmerica Corporation (PMC) Sees Significant Growth in Short InterestPharmerica Corporation (PMC) Sees Significant Growth in Short Interest
www.americanbankingnews.com - August 31 at 1:46 AM
Pharmerica Corporation (PMC) Given Average Recommendation of "Hold" by BrokeragesPharmerica Corporation (PMC) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 28 at 2:36 AM
Comparing Pharmerica Corporation (PMC) and MWI Veterinary Supply (MWIV)Comparing Pharmerica Corporation (PMC) and MWI Veterinary Supply (MWIV)
www.americanbankingnews.com - August 22 at 8:30 AM
Analyzing Pharmerica Corporation (PMC) & MWI Veterinary Supply (MWIV)Analyzing Pharmerica Corporation (PMC) & MWI Veterinary Supply (MWIV)
www.americanbankingnews.com - August 20 at 4:22 AM
MWI Veterinary Supply (MWIV) and Pharmerica Corporation (PMC) Financial ReviewMWI Veterinary Supply (MWIV) and Pharmerica Corporation (PMC) Financial Review
www.americanbankingnews.com - August 14 at 12:28 AM
Head to Head Review: Pharmerica Corporation (NYSE:PMC) & Cardinal Health (CAH)Head to Head Review: Pharmerica Corporation (NYSE:PMC) & Cardinal Health (CAH)
www.americanbankingnews.com - August 10 at 10:24 PM
Pharmerica Corporation (NYSE:PMC) Lowered to "Overweight" at KeyCorpPharmerica Corporation (NYSE:PMC) Lowered to "Overweight" at KeyCorp
www.americanbankingnews.com - August 8 at 8:56 PM
Research Analysts Offer Predictions for Pharmerica Corporations Q4 2018 Earnings (PMC)Research Analysts Offer Predictions for Pharmerica Corporation's Q4 2018 Earnings (PMC)
www.americanbankingnews.com - August 7 at 9:30 AM
Pharmerica Corporation (PMC) Cut to "Neutral" at Credit Suisse GroupPharmerica Corporation (PMC) Cut to "Neutral" at Credit Suisse Group
www.americanbankingnews.com - August 6 at 9:40 PM
Pharmerica Corporation to Post Q3 2017 Earnings of $0.50 Per Share, Barrington Research Forecasts (NYSE:PMC)Pharmerica Corporation to Post Q3 2017 Earnings of $0.50 Per Share, Barrington Research Forecasts (NYSE:PMC)
www.americanbankingnews.com - August 4 at 7:22 AM
PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : August 3, 2017PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : August 3, 2017
finance.yahoo.com - August 4 at 7:05 AM
Healthcare Q2 Earnings to Watch Out on Aug 4: WCG & PMCHealthcare Q2 Earnings to Watch Out on Aug 4: WCG & PMC
finance.yahoo.com - August 4 at 7:05 AM
PHARMERICA CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by KKR & Co. L.P. Unit May be Unfair to ShareholdersPHARMERICA CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by KKR & Co. L.P. Unit May be Unfair to Shareholders
finance.yahoo.com - August 4 at 7:05 AM
PHARMERICA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PharMerica CorporationPHARMERICA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PharMerica Corporation
finance.yahoo.com - August 4 at 7:05 AM
PHARMERICA CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of BuyoutPHARMERICA CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
finance.yahoo.com - August 4 at 7:05 AM
Bragar Eagel & Squire, P.C. Is Investigating the Board of Directors of PharMerica Corporation (PMC) on Behalf of Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Is Investigating the Board of Directors of PharMerica Corporation (PMC) on Behalf of Stockholders and Encourages Investors to Contact the Firm
finance.yahoo.com - August 4 at 7:05 AM
PharMerica Corp.: Strong price momentum but will it sustain?PharMerica Corp.: Strong price momentum but will it sustain?
finance.yahoo.com - August 4 at 7:05 AM
Pharmerica Corporation (PMC) Receives Average Rating of "Hold" from BrokeragesPharmerica Corporation (PMC) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - August 4 at 12:18 AM
Pharmerica Corporation (NYSE:PMC) Rating Reiterated by UBS AGPharmerica Corporation (NYSE:PMC) Rating Reiterated by UBS AG
www.americanbankingnews.com - August 3 at 10:28 PM
Pharmerica Corporation (PMC) Forecasted to Post FY2017 Earnings of $1.91 Per SharePharmerica Corporation (PMC) Forecasted to Post FY2017 Earnings of $1.91 Per Share
www.americanbankingnews.com - August 3 at 9:50 AM
PharMerica To Be Acquired By KKR In Approximately $1.4 Bln Deal - Quick FactsPharMerica To Be Acquired By KKR In Approximately $1.4 Bln Deal - Quick Facts
www.rttnews.com - August 3 at 7:01 AM
KKR to take PharMerica private in $1.4 billion dealKKR to take PharMerica private in $1.4 billion deal
www.reuters.com - August 3 at 7:01 AM
PharMerica (PMC) Alert: J&W Investigates Proposed Sale of PharMerica Corporation; Is $29.25 a Fair Price?PharMerica (PMC) Alert: J&W Investigates Proposed Sale of PharMerica Corporation; Is $29.25 a Fair Price?
www.bizjournals.com - August 3 at 7:01 AM
WeissLaw LLP: PharMerica Corp. Acquisition May Not Be in the Best Interests of PMC ShareholdersWeissLaw LLP: PharMerica Corp. Acquisition May Not Be in the Best Interests of PMC Shareholders
www.prnewswire.com - August 3 at 7:00 AM
Pharmerica (PMC) to Be Acquired by KKR for $29.25 per SharePharmerica (PMC) to Be Acquired by KKR for $29.25 per Share
www.streetinsider.com - August 3 at 7:00 AM
The Law Offices of Vincent Wong Notifies Investors of an Investigation into Possible Breaches of Fiduciary Duty by the Board of PharMerica Corporation in Connection with the Sale of the Company to KR and Walgreens Boots Alliance, Inc.The Law Offices of Vincent Wong Notifies Investors of an Investigation into Possible Breaches of Fiduciary Duty by the Board of PharMerica Corporation in Connection with the Sale of the Company to KR and Walgreens Boots Alliance, Inc.
finance.yahoo.com - August 3 at 7:00 AM

Social Media

Financials

Chart

Pharmerica Corporation (NYSE PMC) Chart for Friday, November, 17, 2017
Loading chart…

This page was last updated on 11/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.